BIEM Stock Overview
Engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bioera S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.035 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.67 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -98.63% |
| 5 Year Change | -99.41% |
| Change since IPO | -99.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIEM | GB Personal Products | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 0.5% |
| 1Y | n/a | 19.1% | 2.7% |
Return vs Industry: Insufficient data to determine how BIEM performed against the UK Personal Products industry.
Return vs Market: Insufficient data to determine how BIEM performed against the UK Market.
Price Volatility
| BIEM volatility | |
|---|---|
| BIEM Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BIEM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BIEM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3 | n/a | www.bioera.it |
Bioera S.p.A. engages in the production and sale of organic products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names. Bioera S.p.A. distributes its products through outsourcers.
Bioera S.p.A. Fundamentals Summary
| BIEM fundamental statistics | |
|---|---|
| Market cap | €932.60k |
| Earnings (TTM) | -€3.99m |
| Revenue (TTM) | €606.00k |
1.5x
P/S Ratio-0.2x
P/E RatioIs BIEM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIEM income statement (TTM) | |
|---|---|
| Revenue | €606.00k |
| Cost of Revenue | €1.05m |
| Gross Profit | -€441.00k |
| Other Expenses | €3.55m |
| Earnings | -€3.99m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | -72.77% |
| Net Profit Margin | -657.92% |
| Debt/Equity Ratio | -60.2% |
How did BIEM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/26 20:10 |
| End of Day Share Price | 2023/09/28 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioera S.p.A. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|